Moderna's combo flu and Covid jab boosts protection

theguardian.com

A clinical trial by Moderna shows a combined flu and Covid vaccine elicits higher immune responses than separate shots. Results from a phase 3 trial of 8,000 participants indicate increased protection against both diseases. Moderna aims to make the vaccine widely available next year. CEO Stéphane Bancel highlights the potential of combination vaccines in reducing respiratory virus burdens. Boots in England offers Pfizer-BioNTech jabs for £98.95 to customers aged 12 and over.


With a significance score of 4, this news ranks in the top 3.9% of today's 22361 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Moderna's combo flu and Covid jab boosts protection | News Minimalist